Tumor antigens derived from dead and dying tumor cells are processed by dendritic cells and presented by major histocompatibility complex class I and II molecules to antigen-specific CD8-positive (CD8+) and CD4-positive (CD4+) T-cells, respectively, which leads to immune activation.16 This evidence concerns the gene CD8A and neoplasm.